Phillips-Medisize, LLC Sustainability Profile
Phillips-Medisize, LLC, a leading provider in the medical device and pharmaceutical sectors, is headquartered in the United States. Founded in 1964, the company has established a strong presence in key operational regions, including Europe and Asia, focusing on innovative solutions for drug delivery and diagnostic applications. Specialising in design, development, and manufacturing, Phillips-Medisize offers a diverse range of core products, including injection moulded components and complex assemblies. Their commitment to quality and advanced technology sets them apart in the industry. Recognised for their market leadership, Phillips-Medisize has achieved significant milestones, including numerous awards for excellence in manufacturing and innovation. With a robust portfolio and a dedication to enhancing patient outcomes, the company continues to shape the future of healthcare solutions.
DitchCarbon Score
How does Phillips-Medisize, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Rubber and Plastic Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Phillips-Medisize, LLC's score of 17 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Phillips-Medisize, LLC's reported carbon emissions
Phillips-Medisize, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Koch Industries, LLC, which may influence its climate commitments and emissions reporting. As of now, Phillips-Medisize has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. Emissions data and climate commitments may be inherited from its parent company, Koch Industries, LLC, which operates under various sustainability initiatives. However, without specific data or targets from Phillips-Medisize, it is challenging to provide a detailed overview of their carbon footprint or reduction efforts. In summary, while Phillips-Medisize, LLC is part of a larger corporate family with potential access to sustainability frameworks, it currently lacks publicly available emissions data and defined climate commitments.
How Carbon Intensive is Phillips-Medisize, LLC's Industry?
How Carbon Intensive is Phillips-Medisize, LLC's Location?
Phillips-Medisize, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Phillips-Medisize, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
